Cutaneous squamous cell carcinoma progression during imiquimod treatment

J Am Acad Dermatol. 2018 Jul;79(1):e11-e12. doi: 10.1016/j.jaad.2018.02.079.

Authors

Emi Dika¹, Pier Alessandro Fanti², Martina Lambertini², Federica Scarfì², Giulia Maria Ravaioli², Giulia Veronesi², Carlotta Baraldi², Alba Guglielmo², Annalisa Patrizi²

Affiliations

¹ Dermatology Department of Experimental, Diagnostic, and Specialty Medicine, University of Bologna, Bologna, Italy. Electronic address: [email protected].
² Dermatology Department of Experimental, Diagnostic, and Specialty Medicine, University of Bologna, Bologna, Italy.

PMID: 29908822
DOI: 10.1016/j.jaad.2018.02.079

No abstract available

Publication types

Letter
Comment

MeSH terms

Administration, Cutaneous
Aminoquinolines
Carcinoma, Squamous Cell*
Disease Progression
Humans
Imiquimod*
Skin Neoplasms

Substances

Aminoquinolines
Imiquimod